virtual seminars it couldn't be easier

Clinical Translation of Tissue Engineering Technologies: Challenges and Opportunities

Next-generation cryopreservation techniques to overcome limitations of legacy approaches
presented by Genetic Engineering News and Cell Preservation Technology journal

Presented by:
Anthony Atala, MD
The William Boyce Professor and Director, Wake Forest Institute for Regenerative Medicine

Moderated by:
Peter C. Johnson, M.D.
Executive VP, Life Sciences and Chief Medical Officer, Paradigm Genetics

Registration for the live event is now closed. However, if you are interested in viewing an online recording which contains the entire presentation, including audio, you may purchase this for $169 USD. Please click the button below and you will be emailed information on how to access the recorded event. MAC USERS: Unfortunately at this time the recordings cannot be viewed on the MAC OS.

This live webcast addressed how to surmount the scientific hurdles that impede the successful application of tissue engineering products from the laboratory to the patient.

With over 60 years of scientific inquiry into the field of tissue engineering and the first application of an engineered tissue product 23 years ago, why are there so few clinical advances to date? Numerous challenges have slowed the wide dissemination of engineered tissues; however, new, promising technologies are now on the horizon. This webcast will focus on how we can move these technologies forward and what it will take to successfully translate tissue engineered products from the bench to the bedside. The scientific challenges, regulatory hurdles, manufacturing, and cost issues involved in advancing the clinical application of these newly engineered tissue products will also be discussed.

The 1½–hour presentation addressed:

  • How to resolve the scientific challenges that slow the developmentof engineered tissues
  • How to approach the stepwise commercialization of an engineered tissue
  • How to identify and avoid clinical development obstacles during the commercialization of an engineered tissue
  • How to enhance the appeal of tissue engineered products for both physicians and patients

An extensive Q&A session, with worldwide participation followed.

Participate in this Virtual Seminar. You can attend this real-time tutorial from anywhere you have an Internet connection.

One Low Registration Fee of $149 entitled you to a site registration, which enables you and unlimited additional colleagues and staff to participate, whether gathered around a computer or in a conference room with speakerphone and screen.

It Couldn’t Be Easier! You’ll view the presentation over your Web browser. On a separate telephone line (which can be put on speakerphone), you will hear the audio and be able to ask questions of the presenter and moderator. You can also submit questions by your keyboard.

Time Well Spent! No travel, no time away. GEN’s hour-and-a-half virtual seminars are authoritative presentations by industry leaders that include ample time for questions and discussion. Registrations will be limited to ensure interactive participation.

Presented by Genetic Engineering News & Cell Preservation Technology Journal